Artificial Intelligence in Drug Interactions and Dose Control — Artificial Intelligence in Pharmacy

Gains:

Ability to evaluate the evidence quality and limit of the output when pre-screening drug-drug, drug-food and drug-disease interactions with artificial intelligence
Ability to cross-validate artificial intelligence output with independent calculation and SmPC in dose, unit and application frequency calculations
Ability to understand that ultimate responsibility for interaction and dosage decisions rests with the competent pharmacist and that clinical significance must be evaluated within the patient context.

At the heart of pharmacy are two questions: "Are these drugs safe together?" and “Is this dose right for this patient?” These two questions are asked hundreds of times every day, and each directly touches patient safety. Artificial intelligence can speed up pre-screening of these questions; It puts the possible interactions in front of you in a list, reminds you of the dosage logic, and points out a point you have forgotten. But the difference between “possible interaction” and “clinically meaningful interaction for this patient” is the essence of your profession, and you make that difference, not the AI. In this unit you will learn how to make artificial intelligence a safe pre-screening tool for interaction and dose control.

Three types of drug interactions

An interaction is when one substance changes the effect of another substance. There are three main types:

Drug-drug interaction: Two drugs increase or decrease the effect of each other. Example: Concomitant use of warfarin (blood thinner) and some antibiotics may increase the risk of bleeding.
Drug-nutrient interaction: A food alters the absorption or metabolism of a drug. Example: grapefruit juice may increase blood levels of some medications.
Drug-disease interaction: A drug may worsen a patient's existing disease. Example: some painkillers may be harmful in heart failure or kidney disease.

AI can screen for all three types, but it is the pharmacist's job to evaluate the clinical relevance of each alert (whether it actually requires intervention) in the context of the patient.

Caution: Even interaction databases distinguish between "theoretical" and "clinically meaningful" interaction. AI can list both with equal seriousness. Weigh each alert against the current source to avoid falling into alert fatigue (too many alerts and missing the real one).

Where does artificial intelligence help in dose control

Dose control consists of three steps: knowing the correct dose, adjusting it for the patient, and making the calculation correctly. Artificial intelligence:

Reminds: "Does this drug require dosage adjustment in renal failure?" It provides answers to such questions as a preliminary screening.
Calculation drafts: Quickly outputs routine calculations such as mg/kg calculation, mL conversion, application frequency.
Generates a checklist: Lists things to look for before confirming a dose.

But in all three steps, the final say is in the SmPC (Summary Product Information; the officially approved information text of the drug) and the independent account. AI may misremember a dose, confuse units (mg with mcg), or give the dose for a different indication.

three mini cases

Case 1 — Warfarin and antibiotics. The physician prescribed a new antibiotic for a 72-year-old patient using warfarin. Artificial intelligence warned "increased risk of bleeding, close monitoring of INR is recommended" in the pre-screening. The pharmacist confirmed this warning with the current interaction database and SmPC, informed the physician and reminded the patient of the INR (blood clotting test) control date. AI has become a safety net here; The decision was made with pharmacist-physician coordination.

Case 2 — Pediatric dosage. Syrup was prescribed for a child 4 years old, weighing 16 kg. Dose 15 mg/kg/day in 2 doses per day. The AI calculated “16 × 15 = 240 mg/day, 120 mg per dose.” The pharmacist independently verified the calculation, obtained the concentration of the syrup (e.g. 250 mg/5 mL) from the SmPC and calculated it as 2.4 mL per dose. The AI couldn't give mL because it didn't know the concentration; The pharmacist completed this step himself.

Case 3 — Kidney function. A patient with an estimated creatinine clearance of 25 mL/min was prescribed a medication normally given at full dose. Artificial intelligence said, "This drug may require dosage adjustment in renal failure, confirm from the SmPC." The pharmacist saw in the SmPC that the dose should be halved if the clearance was below 30 mL/min and contacted the physician. Artificial intelligence knocked on the right door, but SPC gave the exact rate.

Step by step interaction and dose control

Set up anonymous context. Prepare the patient's age, weight, kidney/liver status, and complete medication list (without identification).
Request pre-screening. Ask the AI to list interaction and dosage risks.
Filter for clinical significance. Weigh each alert against the current database/SmPC; Is it theoretical or meaningful?
Do the calculation independently. Solve the dose calculation again with unit analysis.
Consult a physician if necessary. If in doubt, contact us; Record the decision and reasoning.

Weak prompt / Strong prompt

Weak: “Do these drugs interact?”

Strong: "List possible drug-drug and drug-disease interactions as a pre-screening for a patient using the following list of medications. Patient: 68 years, heart failure, creatinine clearance ~35 mL/min. Drugs: [list]. For each interaction, write mechanism, likely clinical outcome, and note 'SmPC/database confirmation required'. Clinical decision making; checklist only."

In the powerful prompt, the patient context, medication list, and limit are clear; The output is not a decision, but a checklist to verify.

Four copyable templates

Task: Interaction pre-screening (NOT DECISION).Patient (anonymous): age [...], weight [...], kidney/liver [...], diagnoses [...].Medication list: [...].Output: | Drug pair | Mechanism | Possible outcome | Priority (high/medium/low) | Confirmation source |Note: Add "SPC/database confirmation required" to each line.

Task: Produce dosage checklist.Drug: [...], indication: [...], patient age/weight/function: [...].Sort: 1) Is the standard dosage range known? 2) Is kidney/liver adjustment necessary?3) Maximum risk of overdose? 4) Application frequency/duration? Write "confirm from SmPC" for each item. Don't give an exact number, subtract the point to be checked.

Task: show mg/kg dose calculation STEP BY STEP and write unit analysis.Input: weight [...] kg, dose [...] mg/kg/day, number of doses [...]/day, product concentration [...] mg/mL.Output: mg per day, mg per dose, mL per dose. Show unit at each step.Warning: The pharmacist must independently verify this calculation.

Dosage control caution table according to drug type

Status

The role of artificial intelligence

Mandatory verification

Standard adult dose

Reminder/checklist

SPC dose range

Kidney/liver failure

Signaling that adjustments are needed

Exact rate + clearance calculation from SmPC

Pediatric (mg/kg)

account draft

Independent account + concentration

Narrow therapeutic index drug (e.g. warfarin, digoxin)

Alert highlight

SmPC + monitoring parameter + physician

Common mistakes

Take every warning equally seriously. Theoretical and clinically significant interaction should be separated.
Taking the focus away from artificial intelligence. The product concentration is always taken from the SmPC/label.
Skipping unit confusion. Units such as mg/mcg, mg/mL, % should be clarified in the calculation.
Relaxing on narrow therapeutic index medication. In these drugs, a small mistake is a big risk; follow-up is required.
Delaying consultation with a physician. Communication should not be delayed regarding the meaningful interaction/dose issue.

In summary

Artificial intelligence is a powerful pre-screening and reminder tool in interaction and dose control; It reveals possible risks and speeds up the routine. But it is the pharmacist's duty to distinguish between "likely" and "meaningful for this patient", to obtain the concentration and exact ratio from the SmPC, to independently verify the calculation, and to consult the physician when in doubt. The decision and responsibility remains with the competent pharmacist.

Application task

Create an anonymous patient profile (age, weight, kidney function, 4-5 medications). Ask the AI for interaction pre-screening and a dosage checklist. Compare each alert in the output with a current interaction source and SmPC; Indicate which warning is clinically significant and which is theoretical. Make a dose calculation independently and compare it with the AI result and note the difference.

checklist

[ ] I gave the patient context anonymously and completely.
[ ] I filtered the preliminary interaction screening for clinical significance.
[ ] I confirmed each warning with the current database/SmPC.
[ ] I verified the dose calculation by independent and unit analysis.
[ ] I got the concentration/exact ratio from SPC.
[ ] I exercised additional caution in drugs with a narrow therapeutic index.
[ ] When in doubt, I consulted the doctor and recorded the decision.